Feature | February 22, 2013

ACR Dose Index Registry Surpasses Five Million Scans

Data will help establish national benchmarks for CT dose indices

February 22, 2013 — Since its launch, less than two years ago, more than 5 million computed tomography (CT) scans, and nearly 3 million exams, have been added to the American College of Radiology (ACR) Dose Index Registry (DIR) — bringing the ACR closer to establishing national benchmarks for CT dose indices, which will help ensure patients receive safe, quality imaging care.

The DIR is a radiology data registry that provides standardized, size-adjusted CT dose indices that facilitate meaningful comparisons — allowing imaging facilities to compare their CT dose indices to regional and national values. Information related to dose indices for all CT exams is collected, anonymized, transmitted to the ACR and stored in a database. Institutions are then provided with periodic feedback reports comparing their results by body part and exam type to aggregate results. A sample report containing actual aggregated data from a participating facility is available here: http://bit.ly/127WGpk.

Currently, the DIR has over 600 registered facilities, including private practices, hospital-based facilities and academic centers. Participation in the DIR is voluntary and will help radiologists meet the requirements for a Physician Quality Reporting System registry starting in 2014.

“As our early success demonstrates, patient safety and CT dose optimization is of utmost importance to radiology professionals, including radiologists, medical physicists and radiologic technologists. As we get closer to establishing national benchmarks for CT dose indices, I hope more imaging facilities will consider participating in the DIR. Having the ability to track dose reduction efforts over time and ultimately lower the radiation dose that Americans receive from medical imaging scans is invaluable,” said Richard Morin, Ph.D., chair of the ACR Dose Index Registry.  

The DIR is part of the overall ACR approach to medical radiation reduction, which includes mandatory accreditation of all medical imaging providers and greater adoption of computerized decision support/imaging ordering systems based on ACR appropriateness criteria.

For additional information about the ACR Dose Index Registry: http://bit.ly/VPNTXm

Related Content

Mirada Medical Releases DLCExpert for Radiotherapy Treatment Planning
Technology | Treatment Planning | February 22, 2018
February 22, 2018 — U.K.-based medical imaging software provider Mirada Medical has released DLCExpert, the first com
Aidoc Introduces AI Solution for Whole-Body CT Scan Analysis
News | Artificial Intelligence | February 20, 2018
Deep learning startup company Aidoc announced what it calls the world’s first and only comprehensive, full-body...
Arterys Receives First FDA Clearance for Oncology Imaging Suite With Deep Learning
Technology | Artificial Intelligence | February 15, 2018
Arterys Inc. announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Arterys...
Patients Lack Information About Imaging Exams
News | Patient Engagement | February 14, 2018
Patients and their caregivers desire information about upcoming imaging examinations, but many are not getting it,...
Mirion Technologies Introduces Instadose Radiation Dosimeter
Technology | Radiation Dose Management | February 08, 2018
The Instadose + dosimeter, the latest by Mirion Technologies, transforms...
Planmed Launches Improved Planmed Verity CBCT Scanner
Technology | Computed Tomography (CT) | February 07, 2018
Planmed announced the launch of the improved Planmed Verity cone beam computed tomography (CBCT) scanner for orthopedic...
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
MedyMatch Receives FDA Device Designation for Intracranial Hemorrhage Software
News | Computed Tomography (CT) | February 01, 2018
February 1, 2018 – MedyMatch Technology, a company focused on helping physicians provide accurate patient assessment
Overlay Init